Coave Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
January 9, 2025
Vertical
Genetic Medicines
Funding URL
View Funding Page
Funding Amount
$33,000,000
Company Info
Traction
Coave plans to move two development candidates to CTA/IND-enabling studies in 2026.
Market
Healthcare
Location
Paris, France
Coinvestors
Novo Holdings A/S, Bpifrance, Invus, UI Investissement, Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, Turenne Capital
Company Description

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Genetic Medicines DealsView Funding Announcement